Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating dry eye syndromes

A technology for dry eye syndrome and medicine, which is applied in the field of medicine, can solve the problems of large eye tissue damage and drug resistance, and achieve clear curative effect and good safety.

Inactive Publication Date: 2013-06-12
顾克斌
View PDF1 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Because the tissues of the eye are more sensitive, these drugs have greater damage to the eye tissues, and often cause problems of drug resistance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

experiment example

[0012] Diagnostic criteria: dry eyes, foreign body sensation, fatigue, jealous, photophobia, burning, eye swelling, eye pain; tear function test: tear secretion test I (SCHERMER I) <10mm, tear film rupture time (BUT) <10s. Exclude photosynthesis, lacrimal glands, lacrimal duct obstruction caused by large-scale ocular surface damage with neurological disorders, uncontrolled systemic diseases, wearing contact lenses, recent history of eye surgery or trauma, etc. Disable systemic antihistamines, anticholinergic drugs or other ophthalmic drugs during medication.

[0013] 50 patients with dry eye who met the above diagnostic criteria were selected, including 25 males and 25 females, with an average age of 37 years.

[0014] The decoction prepared in Example 1 was used for treatment, twice a day, taking 50 ml orally each time. One week of treatment is one course. Recheck after 1 week of medication. Carry out the tear test paper test Schirmer test and tear film break time BUT determin...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicine for treating dry eye syndromes. The medicine for treating dry eye syndromes comprises the following components in parts by weight: 5-10 parts of radix scrophulariae, 10-20 parts of dried ginger, 20-30 parts of dogwood, 10-20 parts of platycodon grandiflorum, 15-25 parts of angelica dahurica, 5-15 parts of inula flower, 10-30 parts of cowherb seed, 1-15 parts of motherwort fruit, 10-20 parts of radix sileris, 15-30 parts of capillary artemisia, 20-30 parts of myrobalan, 1-20 parts of fenugreek, 1-20 parts of celandine, 10-25 parts of rhizoma imperatae, 10-30 parts of cocklebur fruit, 1-20 parts of emblic leafflower fruit, 15-20 parts of kamuning, 10-20 parts of semen pharbitidis, 15-20 parts of lychee seed, 15-30 parts of glabrous sarcandra herb, 10-20 parts of clinopodium polycephalum, 10-25 parts of folium sennae, 5-15 parts of aleppo avens, 1-20 parts of uniflower swisscentaury root, 15-25 parts of folium rhododendri daurici, 15-25 parts of potentilla discolor, 10-20 parts of calyx seu fructus physalis, 15-25 parts of white mulberry root-bark, 20-30 parts of lindley eupatorium, 1-20 parts of gorgon euryale seed and 10-25 parts of Chinese azalea flower. All the components of the medicine for treating dry eye syndromes are natural materials, so that the medicine for treating the dry eye syndromes has good safety and clear curative effect and is suitable for large-scale application in clinic.

Description

Technical field [0001] The present invention relates to the field of medicine, in particular to a medicament for treating dry eye syndrome. Background technique [0002] Dry eye syndrome refers to a type of disease that causes the instability of the tear film and damage to the ocular surface due to the abnormal amount or quality of the tear fluid or the abnormal fluid dynamics of the tear fluid, resulting in eye discomfort. The clinical manifestations are dryness, foreign body sensation, burning Sensation, itching, photophobia, jealousy, blurred vision, fluctuations in vision, and fatigue, etc. With the development of social economy and the improvement of people's living standards, the incidence of dry eye has an increasing trend, and there is a trend of younger people. At present, eye drops are often used clinically to treat dry eye. Because the tissues of the eye are relatively sensitive, these drugs are more harmful to the tissues of the eye and often cause the problem of dr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9068A61P27/02
Inventor 宋贤
Owner 顾克斌
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products